Table 2.
Intranasal corticosteroids approved for allergic rhinitisa
Drug | Brand name (maker) | Indications | Formulation | Dose per spray (µg) | Dosing/administration | OTC status |
---|---|---|---|---|---|---|
Beclomethasone dipropionate | Beconase AQ19 (GSK) | Rx: seasonal and perennial allergic rhinitis and nonallergic rhinitis | Aqueous suspension in metered-dose manual-pump spray; pH 5.0–6.8; contains BC (0.02%) and phenylethyl alcohol (0.25%) | 42 | Age ≥12 years: 1–2 sprays per nostril BID Age ≥6–12 years: 1 spray per nostril BID (up to 2 sprays per nostril BID if not responding) |
Rx only |
QNASL dry nasal aerosol28 (TEVA) | Rx: seasonal and perennial allergic rhinitis | Pressurized nonaqueous solution in metered-dose aerosol device with HFA propellant; contains ethanol, no BC | 80 and 40 | Age ≥12 years: 2 – 80 µg sprays per nostril QD Age ≥4–11 years: 1 – 40 µg spray per nostril QD |
Rx only | |
Budesonide | Rhinocort Aqua21 (AstraZeneca); Rhinocort Allergy29 (McNeil Consumer) | Rx: seasonal and perennial allergic rhinitis OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion, runny nose, sneezing, and itchy nose |
Aqueous suspension in metered-dose manual-pump spray; pH 4.5; contains no BC or alcohol | 32 | Age ≥12 years: up to 4 sprays per nostril QD Age 6–<12 years: up to 2 sprays per nostril QD |
OTC |
Ciclesonide | Omnaris nasal spray30 (Sunovion) Zetonna nasal aerosol31 (Sunovion) |
Rx: nasal symptoms associated with seasonal allergic rhinitis in adults and children aged ≥6 years and perennial allergic rhinitis in adults and adolescents aged ≥12 years Rx: Seasonal and perennial allergic rhinitis |
Hypotonic aqueous suspension in metered-dose, manual pump spray; pH 4.5; contains no BC or alcohol Pressurized, metered-dose aerosol canister and actuator containing a solution of ciclesonide in HFA propellant and ethanol; no BC |
50 37 |
Age ≥6 years: 2 sprays per nostril QD Age ≥12 years: 1 spray per nostril QD |
Rx only Rx only |
Flunisolide | Various | Rx: nasal treatment of the symptoms of seasonal or perennial rhinitis | Solution in spray bottle; pH 5.3; contains BC; no alcohol | 25 | Age 6–14 years: 1 spray per nostril TID or 2 sprays per nostril BID Age >14 years: 2 sprays per nostril BID/TID |
Rx only |
Fluticasone furoate | Veramyst32 (GSK) Flonase Sensimist Allergy Relief52 (GSK Consumer Healthcare) |
Rx: seasonal and perennial allergic rhinitis OTC: temporary relief of symptoms due to hay fever or other upper respiratory allergies in children aged ≥2 years and adults: nasal congestion; runny nose; sneezing; itchy nose; and itchy, watery eyes for ages ≥12 years |
Aqueous suspension in metering, atomizing spray pump; pH 6; contains BC (0.015%); no alcohol | 27.5 | Age 2–11 years: 1 spray per nostril QD Age ≥12 years: 2 sprays per nostril QD |
OTCb |
Fluticasone propionate | Flixonase22 (GSK) Flonase Allergy Relief50 (GSK Consumer Healthcare) |
Rx: seasonal and perennial allergic rhinitis, nasal polyps OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion; runny nose; sneezing; itchy nose; itchy, watery eyes |
Aqueous suspension in metering, atomizing spray pump; pH 5–7; contains BC (0.02%) and phenylethyl alcohol (0.25%) | 50 | Age 4–11 years: 1 spray per nostril QD Age ≥12 years: 2 sprays per nostril QD |
OTC |
Mometasone furoate | Nasonex20 (Merck Sharp & Dohme) | Rx: seasonal and perennial allergic rhinitis, nasal polyps, prophylaxis of seasonal allergic rhinitis OTC: treatment of allergic rhinitis (scope of indication varies by country) |
Aqueous suspension in metered-dose, manual pump spray; pH 4.3–4.9; contains BC; no alcohol | 50 | Age 2–11 years: 1 spray per nostril QD Age ≥12 years: 2 sprays per nostril QD |
OTC (outside the USA) |
Triamcinolone acetonide | Nasacort23 (Sanofi) Nasacort Allergy 24HR33 (Chattem, Inc., a Sanofi Company) |
Rx: seasonal and perennial allergic rhinitis OTC: temporary relief of hay fever or other upper respiratory allergy symptoms: nasal congestion; runny nose; sneezing; itchy nose |
Aqueous suspension in metered-dose pump spray; pH 4.5–6.0; contains BC; no alcohol | 55 | Age 2–5 years: 1 spray per nostril QD Age 6–11 years: 1 spray per nostril QD Age ≥12 years: 2 sprays per nostril QD/BID |
OTC |
Notes:
Indications, dosage, and prescription status may vary by country.
Approved by US Food and Drug Administration for OTC use as of August 2016; OTC product is anticipated to be available commercially in 2017.
Abbreviations: BC, benzalkonium chloride; BID, twice daily; HFA, hydrofluoroalkane; OTC, over-the-counter; QD, once daily; Rx, prescription; TID, three times daily.